ReviewJournal of human genetics2026
Congenital diarrhea/enteropathy due to a novel biallelic PERCC1 variant - a case-based review and variant analysis.
Review in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital diarrhea/enteropathy due to inherited biallelic defects in the newly discovered gene PERCC1 has been reported in only a few patients thus far. We utilized whole-exome sequencing (WES) to identify a novel PERCC1 stop-gain variant (c.188C>G, p.Ser63*). Literature review identified 16 additional patients - 13 with large biallelic deletions involving the PERCC1 gene and three with a homozygous single-nucleotide (stop-gain) variant (c.390C>G, p.Tyr130*). Median [range] age at onset of diarrhea in patients with available data (including ours) is 9.5 [1-21] days. Chronic intractable diarrhea often results in growth failure, meriting the utilization of parenteral nutrition (PN), especially during the first few years of life. Discontinuation of PN has been reported in six patients at an age of 8 [4-17] years. Our report highlights the role of WES in identifying PERCC1 variants in patients with congenital diarrhea/enteropathy. Thus far, PERCC1 variants have primarily been identified through targeted testing or whole-genome sequencing.
Indexed as
Identifiers
41577959What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.